IP Library Granted Patent US 8,563,684
Granted Patent B2
US 8,563,684 · App. 13/326,304 · Granted Oct 22, 2013

Tumor antigen protein SART-3 and tumor antigen peptides thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,563,684
App. No.
13/326,304
Granted
Oct 22, 2013
Kind
B2
Abstract

A novel tumor antigen protein and gene therefor, tumor antigen peptides derived from said tumor antigen protein or derivatives thereof as well as medicaments, prophylactics, or diagnostics for tumors using such tumor substances in vitro or in vitro are provided.

Claims (4)

1. An isolated peptide consisting of the amino acid sequence SEQ ID NO: 25, 26 or 29.

2. The isolated peptide according to claim 1 , wherein the peptide is a recombinant polypeptide produced by expressing a recombinant DNA comprising a polynucleotide that encodes the amino acid sequence.

3. A pharmaceutical composition, which comprises as an active ingredient the peptide according to claim 1 .

4. The pharmaceutical composition according to claim 3 , wherein the peptide is a recombinant polypeptide produced by expressing a recombinant DNA comprising a polynucleotide that encodes the amino acid sequence.

Assignments (2)
CHANGE OF ADDRESS OF ASSIGNEE Recorded Oct 16, 2017
From: BRIGHTPATH BIOTHERAPEUTICS CO., LTD.
To: BRIGHTPATH BIOTHERAPEUTICS CO., LTD.
Reel/Frame 044212/0009 →
CHANGE OF NAME Recorded Sep 11, 2017
From: GREEN PEPTIDE CO., LTD.
To: BRIGHTPATH BIOTHERAPEUTICS CO., LTD.
Reel/Frame 043811/0854 →